US02157Q1094
US02157Q1094
Alto Neuroscience, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 66.364.000 | 68.610.000 | 3.3% | |
| Operating Income | -66.364.000 | -68.610.000 | 3.3% |
| Pretax Income | -63.238.000 | -61.431.000 | 2.9% |
| Net Income Common Stockholders | -63.238.000 | -61.431.000 | 2.9% |
| -- | -- | -- | |
| -- | -- | -- |